WL
Wanbury Limited Stock: price and insider trades · India
Wanbury Limited: what insiders have been doing
Insider filings for Wanbury Limited are scarce in the SEBI (PIT + SAST) feed, the latest one published on 28 July 2025. This page will fill in as new trades are disclosed. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 7,810 of 26,914 companies
62.1
score / 100
Value59
Quality65
FCF yld-4.3%
Earn yld10%
EV/EBITDA8.4x
ROE·
Gross mgn56%
Net mgn10%
Debt/EBITDA2.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹195.20
Analyst consensus
Income statement
Revenue₹6.4B
Gross profit₹3.6B56% margin
EBITDA₹1B16% margin
Net income₹661.3M8.6% margin
Valuation
PER (trailing)12.0x
P/Book4.0x
Beta0.18
Balance sheet & cash
Market cap₹6.8B
Total debt₹2.2B
Free Cash Flow-₹280.8M
Debt / Equity155%
Profitability & ownership
% insiders50.3%
% institutions2.1%
Last declaration on 28 July 2025
Declarations4 total
- 9,172,561 shares0.0% of flowEquity SharesSEBI:bb1a27f72e171844793ebd9c40bd85546e0413d5
- 85,000 shares@ ₹10.001.4% of flowEquity SharesSEBI:cc6946d85b2a67994b33eba332a73aeb8f6ccc5f
- 740,743 shares@ ₹10.00100.0% of flowEquity SharesSEBI:40dad8fa2bf13358835c8d0e9dd1f93415c34c2a
- 5,925,231 shares@ ₹10.0098.6% of flowEquity SharesSEBI:5b4add92c8a1df1fc5db4d9dd2c4ff349c601762
4 of 4 declarations
About Wanbury Limited
Wanbury Limited is a company operating in the healthcare and pharmaceutical sector. It is listed on the XBOM market.
